AstraZeneca: Q3 FY 2016 Results (AstraZeneca) - Nov 12, 2016 - Anticipated completion of enrollment in P2a (NCT02334306) trial in Sjögren's syndrome in 2017; Anticipated top-line data from P2a trial in Sjögren's syndrome in H1 2017
Anticipated P2a data • Immunology
|